{"id":"W1981193135","doi":"10.1016/j.ahj.2005.03.029","title":"The Early Glycoprotein IIb/IIIa Inhibition in Non–ST-Segment Elevation Acute Coronary Syndrome (EARLY ACS) trial: A randomized placebo-controlled trial evaluating the clinical benefits of early front-loaded eptifibatide in the treatment of patients with non–ST-segment elevation acute coronary syndrome—Study design and rationale","year":2005,"lang":"en","type":"article","venue":"American Heart Journal","topic":"Acute Myocardial Infarction Research","field":"Medicine","cited_by":88,"is_retracted":false,"has_abstract":false,"ca_institutions":"University of Alberta","funders":"","keywords":"Eptifibatide; Medicine; Acute coronary syndrome; Placebo; Randomized controlled trial; Internal medicine; Cardiology; ST segment; Clinical trial; ST elevation; Electrocardiography; Percutaneous coronary intervention; Myocardial infarction; Pathology","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002637998,0.003350922,0.004797195,0.0004953754,0.0006110889,0.001302928,0.001103595,0.002894377,0.006106362],"category_scores_gemma":[0.002632685,0.0009123103,0.001820921,0.0004820656,0.001745253,0.001251586,0.0005530139,0.004508166,0.001061394],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00041093,"about_ca_system_score_gemma":0.0008377854,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0005326678,"about_ca_topic_score_gemma":0.001217479,"domain_scores_codex":[0.9989568,0.0005882621,0.00006629477,0.0001599245,0.00008667282,0.0001419292],"domain_scores_gemma":[0.9992187,0.0002747483,0.0001401812,0.00006026073,0.00005827556,0.0002478031],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.9836509,0.003853104,0.0003924836,0.001061373,0.0007186299,0.00006790572,0.00003781138,0.0002264876,0.002401797,0.0002741268,0.0005650589,0.006750308],"study_design_scores_gemma":[0.9778737,0.01958787,0.0008090818,0.00003774445,0.0005768147,0.00002591759,0.00001111157,0.0001584432,0.0002254771,0.0001551055,0.0005268512,0.00001186132],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"protocol","genre_scores_codex":[0.9385107,0.01768268,0.003469414,0.003440008,0.002271418,0.02377655,0.003048762,0.0002650597,0.007535493],"genre_scores_gemma":[0.9312314,0.01164771,0.008536621,0.004189554,0.003044862,0.03047033,0.002408395,0.00005383353,0.008417288],"genre_candidate":"protocol","genre_consensus":null,"teacher_disagreement_score":0.006106362,"threshold_uncertainty_score":0.02042788,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.04534038323094234,"score_gpt":0.3526609912596984,"score_spread":0.307320608028756,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}